Bio-Techne Corporation (TECH) Revenue by Segment
Bio-Techne revenue by segment at a glance
In Q3 fiscal 2026 (the quarter ended March 31, 2026), Bio-Techne's largest business segment was Protein Sciences, with $226.15 million or 73% of revenue, down 0.7% from a year earlier. Next: Diagnostics and Spatial Biology (27%).
By product or service, Consumables brought in 83%, Instruments brought in 9% and Service brought in 7% of revenue in Q3 fiscal 2026.
By region, United States brought in 54%, EMEA, excluding UK brought in 24% and China brought in 8% of revenue in Q3 fiscal 2026.
The fastest-growing business segment from a year earlier was Protein Sciences (-0.7%).
From company filings, in USD; latest quarter ended March 31, 2026; quarterly data from Q1 fiscal 2018.
Bio-Techne Corporation
Revenue breakdown
Fiscal quarters, from company filings
Bio-Techne revenue by business segment, last 4 quarters
| Business segment | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Share |
|---|---|---|---|---|---|
| Protein Sciences | $226.2M | $215.1M | $202.2M | $227.7M | 73% |
| Diagnostics and Spatial Biology | $85.6M | $81.2M | $79.5M | $89.2M | 27% |
In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.
Bio-Techne revenue by product or service, last 4 quarters
| Product or service | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Share |
|---|---|---|---|---|---|
| Consumables | $257.3M | $235.4M | $231.6M | $257.8M | 83% |
| Instruments | $27.7M | $29.6M | $21.8M | $26.1M | 9% |
| Service | $21.4M | $22.3M | $27.5M | $27.2M | 7% |
| Royalty | $5.0M | $8.5M | $5.6M | $5.0M | 2% |
In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.
Bio-Techne revenue by region, last 4 quarters
| Region | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Share |
|---|---|---|---|---|---|
| United States | $167.5M | $146.6M | $155.2M | $181.9M | 54% |
| EMEA, excluding UK | $73.4M | $75.4M | $65.1M | $66.5M | 24% |
| China | $26.0M | $26.4M | $24.8M | $24.5M | 8% |
| APAC, excluding Greater China | $21.8M | $22.7M | $19.1M | $21.2M | 7% |
| United Kingdom | $14.9M | $13.7M | $13.2M | $12.9M | 5% |
| Rest of World | $7.8M | $11.1M | $9.0M | $9.2M | 2% |
In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.
Questions and answers
What are Bio-Techne's business segments?
Protein Sciences and Diagnostics and Spatial Biology (as reported for Q3 fiscal 2026).
Which business segment makes the most money for Bio-Techne?
Protein Sciences: $226.15 million, or 73% of revenue, in Q3 fiscal 2026.
What are Bio-Techne's main products and services?
By revenue in Q3 fiscal 2026: Consumables (83%), Instruments (9%), Service (7%) and Royalty (2%).
Where does Bio-Techne make its money?
By region in Q3 fiscal 2026: United States (54%), EMEA, excluding UK (24%), China (8%) and APAC, excluding Greater China (7%).
